Principles of Translational Science in Medicine From Bench to Bedside
-
Form:Einzelkauf Download
-
Sprache:Englisch
-
Auflage:2. Auflage
- 2. Auflage 92,95 € ausgewählt
- 3. Auflage 140,00 €
92,95 €
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
ePUB 3
Kopierschutz
Nein
Family Sharing
Nein
Text-to-Speech
Ja
Erscheinungsdatum
02.04.2015
Herausgeber
Martin WehlingVerlag
Elsevier Science & Techn.Seitenzahl
364 (Printausgabe)
Dateigröße
13464 KB
Auflage
2. Auflage
Sprache
Englisch
EAN
9780128007211
Principles of Translational Science in Medicine: From Bench to Bedside, Second Edition, provides an update on major achievements in the translation of research into medically relevant results and therapeutics.
The book presents a thorough discussion of biomarkers, early human trials, and networking models, and includes institutional and industrial support systems. It also covers algorithms that have influenced all major areas of biomedical research in recent years, resulting in an increasing numbers of new chemical/biological entities (NCEs or NBEs) as shown in FDA statistics.
The book is ideal for use as a guide for biomedical scientists to establish a systematic approach to translational medicine.
- Provides an in-depth description of novel tools for the assessment of translatability of trials to balance risk and improve projects at any given stage of product development
- New chapters deal with translational issues in the fastest growing population (the elderly), case studies, translatability assessment tools, and advances in nanotherapies
- Details IPR issues of translation, especially for public-private-partnerships
- Contains contributions from world leaders in translational medicine, including the former NIH director and authorities from various European regulatory institutions
The book presents a thorough discussion of biomarkers, early human trials, and networking models, and includes institutional and industrial support systems. It also covers algorithms that have influenced all major areas of biomedical research in recent years, resulting in an increasing numbers of new chemical/biological entities (NCEs or NBEs) as shown in FDA statistics.
The book is ideal for use as a guide for biomedical scientists to establish a systematic approach to translational medicine.
- Provides an in-depth description of novel tools for the assessment of translatability of trials to balance risk and improve projects at any given stage of product development
- New chapters deal with translational issues in the fastest growing population (the elderly), case studies, translatability assessment tools, and advances in nanotherapies
- Details IPR issues of translation, especially for public-private-partnerships
- Contains contributions from world leaders in translational medicine, including the former NIH director and authorities from various European regulatory institutions
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice